Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Rosiglitazone in Non-Diabetic Metabolic Syndrome
NCT04148183Phase 3Completed
- Start
- Jan 2004
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs), rosiglitazone in metabolic syndrome. Started Jan 2004; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)rosiglitazone
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT04148183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148183.